What is the cost of Zydelig?

What is the cost of Zydelig?

The cost for Zydelig oral tablet 100 mg is around $12,298 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans. Zydelig is available as a brand name drug only, a generic version is not yet available.

Who developed Idelalisib?

Idelalisib is a PI3Kδ-specific inhibitor, originally developed by Calistoga as CAL-101 but later acquired by Gilead. A phase-III study of rituximab with or without idelalisib was carried out for patients with chronic lymphocytic leukemia (CLL) relapsed after a prior anti-CD20 therapy or two lines of chemotherapy.

What is Zydelig used for?

ZYDELIG is a prescription medicine used to treat adults with: Chronic Lymphocytic Leukemia (CLL) in combination with Rituxan ® (rituximab) when CLL comes back after prior cancer treatment and when Rituxan treatment alone may be used due to other health problems.

Is Idelalisib a chemotherapy?

Idelalisib is the generic name for the trade chemotherapy drug Zydelig®. In some cases, health care professionals may use the trade name Zydelig® when referring to the generic drug idelalisib. Drug type: Idelalisib is a targeted therapy.

What happens if I touch chlorambucil?

Chlorambucil can cause a severe allergic reaction. Symptoms can include: widespread redness and rash on your skin. skin peeling.

What is Zydelig used for in CLL?

In CLL, Zydelig is used in combination with another medicine (rituximab or ofatumumab) in patients who have received at least one previous treatment and in patients whose cancer cells have genetic mutations (changes) called 17p deletion or TP53 mutation and who cannot be treated with any other therapy.

What is the active substance in Zydelig?

Zydelig contains the active substance idelalisib. Zydelig can only be obtained with a prescription and treatment should be prescribed by a doctor experienced in using cancer medicines. Zydelig is available as 100 mg and 150 mg tablets.

Is Zydelig authorised in the EU?

This medicine is authorised for use in the European Union. Zydelig is a cancer medicine that is used to treat chronic lymphocytic leukaemia (CLL, a cancer of a type of white blood cells called B lymphocytes) and follicular lymphoma (another cancer that affects B lymphocytes).

What are the side effects of Zydelig?

Discontinue ZYDELIG permanently in patients who experience intestinal perforation. Severe cutaneous reactions: Fatal cases of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have occurred in patients treated with ZYDELIG. Cases of drug reaction with eosinophilia and systemic symptoms (DRESS) have also occurred.